BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suárez-Fueyo A, Bradley SJ, Klatzmann D, Tsokos GC. T cells and autoimmune kidney disease. Nat Rev Nephrol 2017;13:329-43. [PMID: 28287110 DOI: 10.1038/nrneph.2017.34] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Schrezenmeier E, Jayne D, Dörner T. Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives. J Am Soc Nephrol 2018;29:741-58. [PMID: 29326157 DOI: 10.1681/ASN.2017040367] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
2 Qiao YC, Pan YH, Ling W, Tian F, Chen YL, Zhang XX, Zhao HL. The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease. Autoimmun Rev 2017;16:1058-70. [PMID: 28778708 DOI: 10.1016/j.autrev.2017.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
3 Suarez-Fueyo A, Tsokos MG, Kwok SK, Maeda K, Katsuyama E, Lapchak PH, Tsokos GC. Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus. Front Immunol 2019;10:2172. [PMID: 31572382 DOI: 10.3389/fimmu.2019.02172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Motavalli R, Etemadi J, Soltani-Zangbar MS, Ardalan MR, Kahroba H, Roshangar L, Nouri M, Aghebati-Maleki L, Khiavi FM, Abediazar S, Mehdizadeh A, Hojjat-Farsangi M, Mahmoodpoor A, Kafil HS, Zolfaghari M, Ahmadian Heris J, Yousefi M. Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy. Cytokine 2021;141:155452. [PMID: 33571932 DOI: 10.1016/j.cyto.2021.155452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Khodoun M, Chimote AA, Ilyas FZ, Duncan HJ, Moncrieffe H, Kant KS, Conforti L. Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus. Sci Adv 2020;6:eabd1471. [PMID: 33208373 DOI: 10.1126/sciadv.abd1471] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Fang H, Li Q, Wang G. The role of T cells in pemphigus vulgaris and bullous pemphigoid. Autoimmunity Reviews 2020;19:102661. [DOI: 10.1016/j.autrev.2020.102661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Adamichou C, Georgakis S, Bertsias G. Cytokine targets in lupus nephritis: Current and future prospects. Clinical Immunology 2019;206:42-52. [DOI: 10.1016/j.clim.2018.08.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Salem D, Subang R, Kuwana M, Levine JS, Rauch J. T cells from induced and spontaneous models of SLE recognize a common T cell epitope on β2-glycoprotein I. Cell Mol Immunol 2019;16:685-93. [PMID: 29572548 DOI: 10.1038/s41423-018-0013-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Krohn S, Nies JF, Kapffer S, Schmidt T, Riedel JH, Kaffke A, Peters A, Borchers A, Steinmetz OM, Krebs CF, Turner JE, Brix SR, Paust HJ, Stahl RAK, Panzer U. IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation. J Am Soc Nephrol 2018;29:1210-22. [PMID: 29483158 DOI: 10.1681/ASN.2017090949] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
10 Zhou C, Sun L, Zhao L, Zhang X. Advancement in regional immunity and its clinical implication. Sci China Life Sci 2017;60:1178-90. [PMID: 29170892 DOI: 10.1007/s11427-017-9224-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Motavalli R, Etemadi J, Kahroba H, Mehdizadeh A, Yousefi M. Immune system-mediated cellular and molecular mechanisms in idiopathic membranous nephropathy pathogenesis and possible therapeutic targets. Life Sciences 2019;238:116923. [DOI: 10.1016/j.lfs.2019.116923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Turner JE, Rickassel C, Healy H, Kassianos AJ. Natural Killer Cells in Kidney Health and Disease. Front Immunol 2019;10:587. [PMID: 30972076 DOI: 10.3389/fimmu.2019.00587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, Liu J, Zhang X, Zhang X, Jin Y, Wang Y, Zhang S, Zhu L, Jacob A, Jia R, You X, Li X, Li C, Zhou Y, Yang Y, Ye H, Liu Y, Su Y, Shen N, Alexander J, Guo J, Ambrus J, Lin X, Yu D, Sun X, Li Z. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 2020;79:141-9. [PMID: 31537547 DOI: 10.1136/annrheumdis-2019-215396] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 22.0] [Reference Citation Analysis]
14 Zuo Z, Jing K, Wu H, Wang S, Ye L, Li Z, Yang C, Pan Q, Liu WJ, Liu HF. Mechanisms and Functions of Mitophagy and Potential Roles in Renal Disease. Front Physiol 2020;11:935. [PMID: 32903665 DOI: 10.3389/fphys.2020.00935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Leon J, Pérez-sáez MJ, Batal I, Beck LH, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV. Membranous Nephropathy Posttransplantation: An Update of the Pathophysiology and Management. Transplantation 2019;103:1990-2002. [DOI: 10.1097/tp.0000000000002758] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
16 Nagai K. Co-inhibitory Receptor Signaling in T-Cell-Mediated Autoimmune Glomerulonephritis. Front Med (Lausanne) 2020;7:584382. [PMID: 33251233 DOI: 10.3389/fmed.2020.584382] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Inoue T, Tanaka S, Okusa MD. Neuroimmune Interactions in Inflammation and Acute Kidney Injury. Front Immunol 2017;8:945. [PMID: 28848551 DOI: 10.3389/fimmu.2017.00945] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
18 Kolovou K, Laskari K, Roumelioti M, Tektonidou MG, Panayiotidis P, Boletis JN, Marinaki S, Sfikakis PP. B-cell oligoclonal expansions in renal tissue of patients with immune-mediated glomerular disease. Clin Immunol 2020;217:108488. [PMID: 32479988 DOI: 10.1016/j.clim.2020.108488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Jamaly S, Rakaee M, Abdi R, Tsokos GC, Fenton KA. Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis. Autoimmun Rev 2021;:102980. [PMID: 34718163 DOI: 10.1016/j.autrev.2021.102980] [Reference Citation Analysis]
20 Black LM, Lever JM, Agarwal A. Renal Inflammation and Fibrosis: A Double-edged Sword. J Histochem Cytochem 2019;67:663-81. [PMID: 31116067 DOI: 10.1369/0022155419852932] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
21 Riedel JH, Turner JE, Panzer U. T helper cell trafficking in autoimmune kidney diseases. Cell Tissue Res 2021. [PMID: 33598825 DOI: 10.1007/s00441-020-03403-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Qing X, Chinenov Y, Redecha P, Madaio M, Roelofs JJ, Farber G, Issuree PD, Donlin L, Mcllwain DR, Mak TW, Blobel CP, Salmon JE. iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling. J Clin Invest 2018;128:1397-412. [PMID: 29369823 DOI: 10.1172/JCI97650] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 10.8] [Reference Citation Analysis]
23 Rudqvist NP, Galluzzi L. T Cells: Friends and Foes. Int Rev Cell Mol Biol 2018;341:ix-xii. [PMID: 31560344 DOI: 10.1016/S1937-6448(18)30104-7] [Reference Citation Analysis]
24 Hutton HL, Alikhan MA, Kitching AR. Inflammasomes in the Kidney. Exp Suppl 2018;108:177-210. [PMID: 30536172 DOI: 10.1007/978-3-319-89390-7_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Nelson PJ, Kretzler M. Defining Renal Neoplastic Disease, One Cell at a Time: Mass Cytometry, a New Tool for the Study of Kidney Biology and Disease. Am J Kidney Dis 2017;70:758-61. [PMID: 29031857 DOI: 10.1053/j.ajkd.2017.08.009] [Reference Citation Analysis]
26 Mutalib M. Renal involvement in paediatric inflammatory bowel disease. Pediatr Nephrol 2021;36:279-85. [PMID: 31820145 DOI: 10.1007/s00467-019-04413-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Angeletti A, Arrigo S, Madeo A, Molteni M, Vietti E, Arcuri L, Coccia MC, Gandullia P, Ghiggeri GM. Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature. BMC Nephrol 2021;22:146. [PMID: 33888087 DOI: 10.1186/s12882-021-02358-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Scindia Y, Wlazlo E, Ghias E, Cechova S, Loi V, Leeds J, Ledesma J, Helen C, Swaminathan S. Modulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis. Kidney Int 2020;98:100-15. [PMID: 32444136 DOI: 10.1016/j.kint.2020.01.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kwok SK, Tsokos GC. New insights into the role of renal resident cells in the pathogenesis of lupus nephritis. Korean J Intern Med 2018;33:284-9. [PMID: 29320847 DOI: 10.3904/kjim.2017.383] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
30 Frangou E, Georgakis S, Bertsias G. Update on the cellular and molecular aspects of lupus nephritis. Clin Immunol 2020;216:108445. [PMID: 32344016 DOI: 10.1016/j.clim.2020.108445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Li H, Tsokos MG, Bhargava R, Adamopoulos IE, Menn-Josephy H, Stillman IE, Rosenstiel P, Jordan J, Tsokos GC. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation. J Clin Invest 2021;131:142428. [PMID: 33956666 DOI: 10.1172/JCI142428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Berg SIT, Knapp J, Braunstein M, Shirriff C. The small heat shock protein HSPB5 attenuates the severity of lupus nephritis in lupus-prone mice. Autoimmunity 2022;:1-11. [PMID: 35137667 DOI: 10.1080/08916934.2022.2027921] [Reference Citation Analysis]
33 Moschovaki-Filippidou F, Steiger S, Lorenz G, Schmaderer C, Ribeiro A, von Rauchhaupt E, Cohen CD, Anders HJ, Lindenmeyer M, Lech M. Growth Differentiation Factor 15 Ameliorates Anti-Glomerular Basement Membrane Glomerulonephritis in Mice. Int J Mol Sci 2020;21:E6978. [PMID: 32977372 DOI: 10.3390/ijms21196978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Krebs CF, Reimers D, Zhao Y, Paust HJ, Bartsch P, Nuñez S, Rosemblatt MV, Hellmig M, Kilian C, Borchers A, Enk LUB, Zinke M, Becker M, Schmid J, Klinge S, Wong MN, Puelles VG, Schmidt C, Bertram T, Stumpf N, Hoxha E, Meyer-Schwesinger C, Lindenmeyer MT, Cohen CD, Rink M, Kurts C, Franzenburg S, Koch-Nolte F, Turner JE, Riedel JH, Huber S, Gagliani N, Huber TB, Wiech T, Rohde H, Bono MR, Bonn S, Panzer U, Mittrücker HW. Pathogen-induced tissue-resident memory TH17 (TRM17) cells amplify autoimmune kidney disease. Sci Immunol 2020;5:eaba4163. [PMID: 32769171 DOI: 10.1126/sciimmunol.aba4163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
35 Lin JX, Leonard WJ. The Common Cytokine Receptor γ Chain Family of Cytokines. Cold Spring Harb Perspect Biol 2018;10:a028449. [PMID: 29038115 DOI: 10.1101/cshperspect.a028449] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
36 Schmidt T, Luebbe J, Kilian C, Riedel J, Hiekmann S, Asada N, Ginsberg P, Robben L, Song N, Kaffke A, Peters A, Borchers A, Flavell RA, Gagliani N, Pelzcar P, Huber S, Huber TB, Turner J, Paust H, Krebs CF, Panzer U. IL-17 Receptor C Signaling Controls CD4 + T H 17 Immune Responses and Tissue Injury in Immune-Mediated Kidney Diseases. JASN 2021;32:3081-98. [DOI: 10.1681/asn.2021030426] [Reference Citation Analysis]
37 Sadasivam M, Noel S, Lee SA, Gong J, Allaf ME, Pierorazio P, Rabb H, Hamad ARA. Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2. J Am Soc Nephrol 2019;30:277-92. [PMID: 30622155 DOI: 10.1681/ASN.2018080815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
38 Barbari A. Continuing the paradigm shift in the treatment of idiopathic membranous nephropathy. Nat Rev Nephrol 2017;13:720-720. [DOI: 10.1038/nrneph.2017.134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
39 Diao L, Li M, Tao J, Xu X, Wang Y, Hu Y. Therapeutic effects of cationic liposomes on lupus-prone MRL/lpr mice are mediated via inhibition of TLR4-triggered B-cell activation. Nanomedicine 2021;40:102491. [PMID: 34781040 DOI: 10.1016/j.nano.2021.102491] [Reference Citation Analysis]
40 Santos JE, Fiel D, Santos R, Vicente R, Aguiar R, Santos I, Amoedo M, Pires C. Rituximab use in adult glomerulopathies and its rationale. J Bras Nefrol 2020;42:77-93. [PMID: 31904761 DOI: 10.1590/2175-8239-JBN-2018-0254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
41 Santoro D, Vadalà C, Siligato R, Buemi M, Benvenga S. Autoimmune Thyroiditis and Glomerulopathies. Front Endocrinol (Lausanne) 2017;8:119. [PMID: 28626447 DOI: 10.3389/fendo.2017.00119] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
42 Abdirama D, Tesch S, Grießbach AS, von Spee-Mayer C, Humrich JY, Stervbo U, Babel N, Meisel C, Alexander T, Biesen R, Bacher P, Scheffold A, Eckardt KU, Hiepe F, Radbruch A, Burmester GR, Riemekasten G, Enghard P. Nuclear antigen-reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys. Kidney Int 2021;99:238-46. [PMID: 32592813 DOI: 10.1016/j.kint.2020.05.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
43 Santos JE, Fiel D, Santos R, Vicente R, Aguiar R, Santos I, Amoedo M, Pires C. Rituximab use in adult glomerulopathies and its rationale. J Bras Nefrol. 2020;42:77-93. [PMID: 31904761 DOI: 10.1590/2175-8239-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Zhang X, Feng R, Shao M, Wang Y, Sun X, He J. Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis. Rheumatol Ther 2021;8:1905-14. [PMID: 34618348 DOI: 10.1007/s40744-021-00381-1] [Reference Citation Analysis]
45 Chen A, Lee K, D'Agati VD, Wei C, Fu J, Guan TJ, He JC, Schlondorff D, Agudo J. Bowman's capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells. J Clin Invest 2018;128:3413-24. [PMID: 29985168 DOI: 10.1172/JCI97879] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
46 Chen L, Yang T, Lu D, Zhao H, Feng Y, Chen H, Chen D, Vaziri ND, Zhao Y. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Biomedicine & Pharmacotherapy 2018;101:670-81. [DOI: 10.1016/j.biopha.2018.02.090] [Cited by in Crossref: 124] [Cited by in F6Publishing: 120] [Article Influence: 31.0] [Reference Citation Analysis]
47 Liu Q, Liu J, Lin B, Zhang Y, Ma M, Yang M, Qin X. Novel Biomarkers in Membranous Nephropathy. Front Immunol 2022;13:845767. [DOI: 10.3389/fimmu.2022.845767] [Reference Citation Analysis]
48 Shao M, He J, Zhang R, Zhang X, Yang Y, Li C, Liu X, Sun X, Li Z. Interleukin-2 Deficiency Associated with Renal Impairment in Systemic Lupus Erythematosus. J Interferon Cytokine Res 2019;39:117-24. [PMID: 30721117 DOI: 10.1089/jir.2018.0016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
49 Yin P, Li J, Wen Q, Qiu Y, Liang W, Wang J, Yu J, Zhong Z, Yang X, Yu X, Ye Q, Huang F. Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients. Ren Fail 2020;42:474-82. [PMID: 32406300 DOI: 10.1080/0886022X.2020.1763400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Li Q, Cao Q, Wang C, Nguyen H, Wang XM, Zheng G, Wang YM, Hu S, Alexander SI, Harris DC, Wang Y. Dendritic cell‐targeted CD40 DNA vaccine suppresses Th17 and ameliorates progression of experimental autoimmune glomerulonephritis. J Leukoc Biol 2018;105:809-19. [DOI: 10.1002/jlb.5a0818-333r] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
51 Krebs CF, Panzer U. Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases. J Autoimmun 2018;87:61-8. [PMID: 29275837 DOI: 10.1016/j.jaut.2017.12.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
52 Zavala-Miranda MF, González-Ibarra SG, Pérez-Arias AA, Uribe-Uribe NO, Mejia-Vilet JM. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination. Kidney Int 2021;100:1340-1. [PMID: 34560139 DOI: 10.1016/j.kint.2021.09.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Rudqvist N, Galluzzi L. T Cells: Friends and Foes. Biology of T Cells - Part B. Elsevier; 2019. pp. xi-xiv. [DOI: 10.1016/s1937-6448(19)30009-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Dorraji SE, Hovd AK, Kanapathippillai P, Bakland G, Eilertsen GØ, Figenschau SL, Fenton KA. Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis. Sci Rep 2018;8:7861. [PMID: 29777158 DOI: 10.1038/s41598-018-26265-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
55 Krebs CF, Turner JE, Riedel JH, Panzer U. Tissue-specific therapy in immune-mediated kidney diseases: new ARGuments for targeting the IL-23/IL-17 axis. J Clin Invest 2021;131:150588. [PMID: 34128472 DOI: 10.1172/JCI150588] [Reference Citation Analysis]
56 Izati AF, Mohd Shukri ND, Wan Ghazali WS, Che Hussin CM, Wong KK. Increased IL-23R+ Th Cells Population Exhibits Higher SLEDAI-2K Scores in Systemic Lupus Erythematosus Patients. Front Immunol 2021;12:690908. [PMID: 34484186 DOI: 10.3389/fimmu.2021.690908] [Reference Citation Analysis]
57 Xue Q, Li X, Gu Y, Wang X, Wang M, Tian J, Duan X, Gao H, Ji X, Yan X, Dong W, Fang Q, Zhang X. Unbalanced Expression of ICOS and PD-1 in Patients with Neuromyelitis Optica Spectrum Disorder. Sci Rep 2019;9:14130. [PMID: 31575949 DOI: 10.1038/s41598-019-50479-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]